This Biotech Stock 355% Breakout: Deep Track Bets Big
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
When to choose an index fund depends on costs, diversification needs, and your time horizon; use these criteria to guide selection.
14,060 articlesA biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
A leading infrastructure stock surged 124% in the past year, even as a major fund dumped roughly $38 million of its s...
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...
JPMorgan Chase is tightening its lending standards for private deals while a $33 billion private credit fund faces he...
A major hedge fund exit grabbed headlines as a fund controlled by William Oberndorf liquidated a sizable monday.com s...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A discreet fund quietly builds a Mattel stake, signaling conviction or a calculated thesis. This article breaks down ...
A major fund stepped in with a bold $30 million wager on Floor & Decor after a sharp 30% decline. This article breaks...
Resolute Holdings stock soars can signal a potent momentum move. This guide breaks down the drivers, evaluates sustai...
A major filming pause on secret lives mormon wives reveals how volatile reality TV income can be. This guide breaks d...
A little-known income ETF has doubled this year by selling covered calls on AMD, outperforming the broad market as th...
DBA closed $68 million for its second venture fund on Feb. 18, 2026, signaling sustained appetite for crypto infrastr...